Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis
Open Access
- 23 February 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (1) , e195-e199
Abstract
Tuberculous meningitis causes substantial mortality due to limited penetration of antibiotics to the central nervous system and excessive neuroinflammation. This study evaluated clofazimine as an adjunct to the standard first-line tuberculosis regimen, in a mouse model. Mice were infected intracerebrally with Mycobacterium tuberculosis and treated for 6 weeks. Addition of clofazimine markedly reduced the brain bacterial burden, achieving measurable brain tissue concentrations despite minimal cerebrospinal fluid penetration, as well as attenuated brain tissue inflammation. These findings indicate that clofazimine enhances bactericidal activity of the standard regimen and mitigate neuroinflammation, supporting further investigation and clinical evaluation for tuberculous meningitis.Keywords
Funding Information
- National Institutes of Health (R01-AI145435-A1)
- National Institutes of Health (R01-AI153349)
- National Institutes of Health (R56-AI179012-A1)
- National Institutes of Health (R01-AI190038)
- National Institutes of Health (S10-OD030381-A1)
This publication has 15 references indexed in Scilit:
- A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trialThe Lancet Infectious Diseases, 2025
- Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trialJournal of Antimicrobial Chemotherapy, 2025
- Clofazimine: A journey of a drugBiomedicine & Pharmacotherapy, 2023
- A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisNew England Journal of Medicine, 2022
- Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential UsefulnessClinical Infectious Diseases, 2021
- The Role of Astrocytes in CNS InflammationTrends in Immunology, 2020
- Tuberculous meningitis: a roadmap for advancing basic and translational researchNature Immunology, 2018
- Evidence for the presence of clofazimine and its distribution in the healthy mouse brainJournal of Molecular Histology, 2015
- Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2015
- Clofazimine: A review of its medical uses and mechanisms of actionJournal of the American Academy of Dermatology, 1995